Results 41 to 50 of about 52,662 (260)

Causes of prehospital misinterpretations of ST elevation myocardial infarction [PDF]

, 2016
Objectives: To determine the causes of software misinterpretation of ST elevation myocardial infarction (STEMI) compared to clinically identified STEMI to identify opportunities to improve prehospital STEMI identification.
Bosson, Nichole, Eckstein, Marc, French, William J., Jollis, James G., Koenig, William, Kontos, Michael C., Macfarlane, Peter W., Niemann, James, Sanko, Stephen, Stickney, Ronald E., Tadeo, Richard, Taylor, Tyson G.   +11 more
core   +1 more source

Management of the acute coronary syndromes

South African Family Practice, 2004
The clinical presentation with an acute coronary syndrome (ACS), is an indication of a serious event (atherosclerotic plaque rupture) occurring in the patient’s coronary artery.
J.M. Bennett
doaj   +1 more source

Non-ST-segment elevation acute coronary syndromes: an algorithm for decision [PDF]

European Heart Journal, 2007
We have read with great interest the report1 of the Task Force concerning the guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes (NST-ACS). We would like to compliment the Task Force members for this excellent work, updating the previous ESC guidelines concerning that matter.
Michel E, Bertrand, Jean Philippe, Collet, Gilles, Montalescot   +2 more
openaire   +2 more sources

Takotsubo cardiomyopathy and sepsis: a systematic review [PDF]

, 2017
Takotsubo cardiomyopathy (TTC) is characterized by a systolic dysfunction localized in the apical and medial aspect of the left ventricle. It is usually related to physical or emotional stress.
Agarwal V, Costantino Ciallella, Geng S, Hutan Ashrafian, Lee S, Mariarosaria Aromatario, Maron BJ, Odigie-Okon E, Pullara A, Sarullo FM, Sato H, Sharkey SW, Sian Harding, Simone Cappelletti, Thanos Athanasiou, Xu RH   +15 more
core   +1 more source

Sudden Cardiac Death After Non–ST-Segment Elevation Acute Coronary Syndrome [PDF]

JAMA Cardiology, 2016
In the current therapeutic era, the risk for sudden cardiac death (SCD) after non-ST-segment elevation acute coronary syndrome (NSTE ACS) has not been characterized completely.To determine the cumulative incidence of SCD during long-term follow-up after NSTE ACS, to develop a risk model and risk score for SCD after NSTE ACS, and to assess the ...
Paul L, Hess, Daniel M, Wojdyla, Sana M, Al-Khatib, Yuliya, Lokhnygina, Lars, Wallentin, Paul W, Armstrong, Matthew T, Roe, E Magnus, Ohman, Robert A, Harrington, John H, Alexander, Harvey D, White, Frans, Van de Werf, Jonathan P, Piccini, Claes, Held, Philip E, Aylward, David J, Moliterno, Kenneth W, Mahaffey, Pierluigi, Tricoci   +17 more
openaire   +2 more sources

Place of Prasugrel, P2Y12 receptor antagonist, in an early invasive treatment of patients with acute coronary syndrome (according to the results of multicenter randomized controlled trial ISAR-REACT 5)

Российский кардиологический журнал, 2019
The conclusion of the Expert Council reports an agreement on the place of the P2Y12 receptor blocker prasugrel in the early invasive treatment of patients with acute coronary syndrome ACS, according to the results of the multicenter randomized controlled
S. N. Tereshchenko, M. G. Glezer, S. A. Abugov, O. V. Averkov, S. I. Antipov, A. S. Galyavich, M. Yu. Gilyarov, D. V. Duplyakov, A. A. Efremushkina, D. A. Zateyshchikov, V. V. Ivanenko, E. D. Kosmacheva, O. V. Krestyaninov, Yu. M. Lopatin, E. P. Panchenko, V. V. Ryabov, E. V. Samokhvalov, I. I. Staroverov, S. A. Ustyugov, A. V. Khripun, S. V. Shalaev, R. M. Shakhnovich, I. S. Yavelov, A. N. Yakovlev, S. S. Yakushin   +24 more
doaj   +1 more source

Troponins, Acute Coronary Syndrome and Renal Disease: From Acute Kidney Injury Through End-stage Kidney Disease [PDF]

, 2019
The diagnosis of acute coronary syndromes (ACS) is heavily dependent on cardiac biomarker assays, particularly cardiac troponins. ACS, particularly non-ST segment elevation MI, are more common in patients with acute kidney injury, chronic kidney disease (
Banerjee, A, Banerjee, D, Ferrett, C
core   +2 more sources

Farnesyltransferase Deficiency in Cardiomyocytes Initiates Senescence and Contributes to Cardiac Fibrosis

Advanced Science, EarlyView.
Lipid overload suppresses SREBF2‐mediated FNTB expression, leading to defective Lamin A maturation and nuclear envelope instability. This nuclear catastrophe triggers a pro‐fibrotic senescence program in cardiomyocytes. Notably, restoring nuclear integrity via AAV9‐based gene therapy effectively attenuates cardiac remodeling, identifying the ...
Yuxiao Chen, Lian Lou, Xuan Zhang, Lin Yan, Qi Zhang, Wen Shi, Jie Ding, Xu Lin, Rong Jiang, Shuo Liu, Thida Sok, Pengli Wang, Yun Mou, Jie Han, Shenjiang Hu, Xiaogang Guo, Jian Yang   +16 more
wiley   +1 more source

Serum Concentrations of Matrix Metalloproteinase‐1 and Procollagen Type I Carboxy Terminal Propeptide Discriminate Infarct‐Like Myocarditis and Non−ST‐Segment−Elevation Myocardial Infarction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Biomarkers simplifying the diagnostic workup by discriminating between non–ST‐segment–elevation myocardial infarction (NSTEMI) and infarct‐like myocarditis are an unmet clinical need.
Lucas Bacmeister, Ersin Cavus, Sebastian Bohnen, Enver Tahir, Hanna Wolf, Annette Buellesbach, Adrian Heidenreich, Virginia K. Haacke, Susanne Weber, Ingo Hilgendorf, Tanja Zeller, Francisco Ojeda, Ulf K. Radunski, Gunnar K. Lund, Gerhard Adam, Stefan Blankenberg, Dirk Westermann, Kai Muellerleile, Diana Lindner   +18 more
doaj   +1 more source

Acute coronary syndrome: analysis of two case reports

Clinical Management Issues, 2009
The patients presenting acute coronary syndrome without ST segment elevation can have a short and long-term risk of death or recurrent ischemic events. Therefore, the evaluation of risk is an essential step in the management of such patients.
Marco Mascellanti
doaj   +1 more source